Treatment of asthma among U.S. adults by type

This statistic depicts the treatment of asthma among U.S. adults in the periods 1998-1999 and 2008-2009, sorted by type of treatment. In the period 1998-1999, 67.7 percent of these adults reported to use any reliever.

Treatment of asthma among adults in the United States in 1998-1999 and 2008-2009, by type*

Characteristic	1998-1999	2008-2009
Controller	54.3%	59.9%
ICS	39.9%	51.2%
LTRA	12.4%	20.4%
Any reliever	67.7%	61.7%
Reliever only	26.8%	26.1%
OCS	13.7%	12.4%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

July 2012

More information

Region

United States

Survey time period

1998-1999 and 2008-2009

Age group

18 years and older

Supplementary notes

* Adults with reported treatment for asthma.
Controllers denotes the use of any controller—include ICS (inhaled corticosteroids), ILABA (inhaled long acting beta-agonists), LTRA (leukotriene receptor antagonists), NSA (non-steroidal anti-allergy agents), MXS (methylxanthines) and OLABA (oral long acting beta-agonists).
Relievers denotes the use of any reliever—include SABA (inhaled short acting beta agonists), ACB (anti-cholinergic bronchodilators) and SANB (shorting acting non-beta selective agents).
Relievers only” indicates reliever use but no controller use.
OCS (oral corticosteroids) denotes the use of any OCS—includes prednisone, dexamethasone, methylprednisolone and other steroids.

Citation formats